Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

The substance is a small aromatic heterocycle with a molecular weight of 107 g/ mol. It is soluble in water at up to 50 g/L at 20°C with a partition coefficient (Log Pow) of 0.714 at 20°C and a vapour pressure of 1.2 hPa at 20°C. With these physical/chemical (phys/chem) properties, oral, dermal and inhalation exposures are all potential routes of exposure.

Once absorbed, the substance is likely to be rapidly metabolized by Phase I oxidation reactions and possible Phase II conjugation. Both unchanged parent and metabolites are likely to be excreted in urine. Therefore bioaccumulation is unlikely.

1. The substance can be assumed to be absorbed by the oral, dermal, and inhalation routes of exposure therefore systemic exposure is likely.

2. The substance is likely to be rapidly metabolized to hydroxy and acid metabolites which could then be conjugated.

3. The substance is unlikely to bioaccumulate because of its polarity, extensive metabolism and rapid excretion.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
100
Absorption rate - dermal (%):
100
Absorption rate - inhalation (%):
100

Additional information

The toxicokinetics of absorption, distribution metabolism and excretion (ADME) of the the substance have not been evaluated in vivo. As a result, this analysis of the toxicokinetics is a qualitative assessment based on physicochemical properties and available information on the substance and 2 structurally related compounds (pyrimidine and nicotinic acid) according to the guidance provided in the ECHA Guidelines ( Guidance on information requirements and chemical safety assessment Chapter R.8: Characterisation of dose [concentration]-response for human health; 2012, ECHA (2014) Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7c: Endpoint specific guidance. Version 2.0 Accessed on April 18, 2018).